Naude Celeste E, Durao Solange, Harper Abigail, Volmink Jimmy
Centre for Evidence-based Health Care, Faculty of Medicine and Health Sciences, Stellenbosch University, Francie van Zijl Drive, Tygerberg, 7505, South Africa.
Cochrane South Africa, South African Medical Research Council, Francie van Zijl Drive, Tygerberg, 7505, South Africa.
Nutr J. 2017 Apr 7;16(1):22. doi: 10.1186/s12937-017-0244-7.
All countries face significant challenges from complex manifestations of malnutrition, which affects one in three people globally. Systematic reviews provide ready-to-use syntheses of quality-appraised evidence to inform decision-making for actions. To enhance the utility and quality of future Cochrane nutrition evidence, we described the scope and quality of all nutrition systematic reviews in the Cochrane Database of Systematic Reviews (CDSR).
We screened all active CDSR records (31 July 2015) to identify reviews and protocols using pre-specified eligibility criteria and definitions. Duplicate, independent data extraction included criteria for inclusion of studies in completed reviews (PICOS). We assessed methodological quality (AMSTAR), use of GRADE, mapped reviews against 2013 Global Burden of Disease data, and categorised the paradigm (medical, lifestyle and socio-ecological) of the review question. We analysed our results using descriptive statistics.
We screened 8484 records, and included 470 (8%) completed reviews (in 45 Cochrane Review Groups (CRGs)) and 169 (7%) protocols (in 41 CRGs) published by 47 of 53 CRGs with reviews. Most completed reviews were produced by the Pregnancy and Childbirth (n = 73), Neonatal (n = 64), Metabolic and Endocrine Disorders (n = 33), Developmental, Psychosocial and Learning Problems (n = 26), Kidney and Transplant (n = 18) and Heart (n = 18) CRGs. Only 27% (n = 129) of reviews had searches for new studies in 2013 or thereafter. Supplementation/supplement interventions were most common (50%; n = 235; majority with micronutrients; 73%, n = 173), followed by food interventions (20%; n = 95). All reviews included randomised controlled trials; about 5% included other designs; 25% used GRADE; the median AMSTAR score was 9 (interquartile range: 7 to 10), 51% were high (AMSTAR 9-11) and 49% moderate (AMSTAR 5-8) quality. More than 80% framed questions using a medical paradigm. For top causes of years-of-life-lost, most reviews addressed preterm birth, diabetes and ischaemic heart disease; for leading risk factors for disability-adjusted-life-years, most targeted childhood undernutrition and high body mass index.
Nutrition reviews comprised 8% of active CDSR records, were widely distributed across nearly all CRGs and reflected the double nutrition burden. This analysis presents a comprehensive description of the scope and quality of Cochrane nutrition reviews, and identifies gaps for future activities to support actions to address the nutrition burden, in line with the current nutrition agenda and impetus.
所有国家都面临着营养不良复杂表现带来的重大挑战,全球三分之一的人口受到影响。系统评价提供了经质量评估的证据的现成综合内容,为行动决策提供信息。为提高未来Cochrane营养证据的实用性和质量,我们描述了Cochrane系统评价数据库(CDSR)中所有营养系统评价的范围和质量。
我们筛选了所有活跃的CDSR记录(2015年7月31日),以使用预先指定的纳入标准和定义来识别评价和方案。重复、独立的数据提取包括已完成评价中纳入研究的标准(PICOS)。我们评估了方法学质量(AMSTAR)、GRADE的使用情况,将评价与2013年全球疾病负担数据进行映射,并对评价问题的范式(医学、生活方式和社会生态)进行分类。我们使用描述性统计分析结果。
我们筛选了8484条记录,纳入了470项(8%)已完成的评价(来自45个Cochrane评价组(CRG))和169项(7%)方案(来自41个CRG),这些评价由53个有评价的CRG中的47个发布。大多数已完成的评价由妊娠与分娩(n = 73)、新生儿(n = 64)、代谢与内分泌疾病(n = 33)、发育、心理社会与学习问题(n = 26)、肾脏与移植(n = 18)以及心脏(n = 18)CRG产生。只有27%(n = 129)的评价在2013年或之后检索了新的研究。补充/补充剂干预最为常见(50%;n = 235;大多数含微量营养素;73%,n = 173),其次是食物干预(20%;n = 95)。所有评价都纳入了随机对照试验;约5%纳入了其他设计;25%使用了GRADE;AMSTAR评分中位数为9(四分位间距:7至10),51%为高质量(AMSTAR 9 - 11),49%为中等质量(AMSTAR 5 - 8)。超过80%的问题采用医学范式提出。对于寿命损失年数的主要原因,大多数评价涉及早产、糖尿病和缺血性心脏病;对于伤残调整生命年的主要危险因素,大多数针对儿童期营养不良和高体重指数。
营养评价占活跃CDSR记录的8%,广泛分布于几乎所有CRG中,并反映了双重营养负担。本分析全面描述了Cochrane营养评价的范围和质量,并确定了未来活动的差距,以支持根据当前营养议程和动力采取行动应对营养负担。